Below are the most recent publications written about "Chylomicrons" by people in Profiles.
-
Drouin-Chartier JP, Tremblay AJ, Lemelin V, Lamarche B, Couture P. Differential associations between plasma concentrations of insulin and glucose and intestinal expression of key genes involved in chylomicron metabolism. Am J Physiol Gastrointest Liver Physiol. 2018 08 01; 315(2):G177-G184.
-
Gelrud A, Williams KR, Hsieh A, Gwosdow AR, Gilstrap A, Brown A. The burden of familial chylomicronemia syndrome from the patients' perspective. Expert Rev Cardiovasc Ther. 2017 Nov; 15(11):879-887.
-
Albers K, Schlein C, Wenner K, Lohse P, Bartelt A, Heeren J, Santer R, Merkel M. Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant. Atherosclerosis. 2014 Mar; 233(1):97-103.
-
Yao M, Xiao H, McClements DJ. Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles. Annu Rev Food Sci Technol. 2014; 5:53-81.
-
Wu L, Piotrowski K, Rau T, Waldmann E, Broedl UC, Demmelmair H, Koletzko B, Stark RG, Nagel JM, Mantzoros CS, Parhofer KG. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial. Metabolism. 2014 Mar; 63(3):382-91.
-
Yao M, Chen J, Zheng J, Song M, McClements DJ, Xiao H. Enhanced lymphatic transport of bioactive lipids: cell culture study of polymethoxyflavone incorporation into chylomicrons. Food Funct. 2013 Nov; 4(11):1662-7.
-
Watts GF, Ribalta J. Progress in understanding postprandial dyslipidaemia: Second International Symposium on the Role of Chylomicrons in Disease l. Atheroscler Suppl. 2010 Jun; 11(1):1-2.
-
Tentolouris N, Eleftheriadou I, Katsilambros N. The effects of medications used for the management of dyslipidemia on postprandial lipemia. Curr Med Chem. 2009; 16(2):203-17.
-
Eleftheriadou I, Grigoropoulou P, Katsilambros N, Tentolouris N. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism. Curr Diabetes Rev. 2008 Nov; 4(4):340-56.
-
Stalenhoef AF, Watts GF. Chylomicrons in disease: a renaissance in lipidology International Symposium of Chylomicrons in Disease (ISCD), Lake Louise, Alberta, Canada, March 6th-8th, 2008. Atheroscler Suppl. 2008 Sep; 9(2):1-2.